Cargando…
Approved and investigational fluorescent optical imaging agents for disease detection in surgery
Fluorescent optical imaging is becoming an increasingly attractive imaging tool that physicians can utilise as it can detect previously ‘unseen’ changes in tissue at a cellular level that are consistent with disease. This is possible using a range of fluorescently labelled imaging agents that, once...
Autores principales: | Rehman, Sonia, Brennan, Paul M., Lilienkampf, Annamaria, Bradley, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442106/ https://www.ncbi.nlm.nih.gov/pubmed/37195806 http://dx.doi.org/10.1097/JS9.0000000000000459 |
Ejemplares similares
-
Solid-Phase Synthesis of Fluorescent Probes for Plasma Membrane Labelling
por: Zhang, Shuo, et al.
Publicado: (2021) -
Fluorophore-Tagged
Poly-Lysine RAFT Agents: Controlled
Synthesis of Trackable Cell-Penetrating Peptide–Polymers
por: Shaw, Paige A., et al.
Publicado: (2023) -
Recommendations for reporting on emerging optical imaging agents to promote clinical approval
por: Tummers, Willemieke S., et al.
Publicado: (2018) -
Tetrazine-mediated bioorthogonal prodrug–prodrug activation
por: Neumann, Kevin, et al.
Publicado: (2018) -
The Performance of FDA-Approved PET Imaging Agents in the Detection of Prostate Cancer
por: Li, Mei, et al.
Publicado: (2022)